2022 Stronger - P158 - Severe Maternal Hypertension and Preeclampsia: A Roadmap to Improvement - On Demand

Many factors have contributed to the rise in U.S. maternal mortality. While the issue has attracted a lot of attention, we’ve seen little substantial improvement. At Atlantic Health System, we approached severe maternal hypertension treatment with engagement, resiliency, accountability, transparency and empowerment across the entire women’s health service line. This led to improved outcomes at both academic and community hospitals — translating to systemwide, sustained improvement. As a result of this housewide collaboration, timeliness to treat severe maternal hypertension improved from 40% in 2018 to over 90% in 2021.

Target Audience

  • Healthcare Quality Professionals
  • Nurses
  • Pharmacists
  • Physicians
  • Other Healthcare Professionals

Learning Objectives

Describe a multidisciplinary approach to appropriately and expeditiously treat severe maternal hypertension.

Discuss successful strategies used within a multisite health system collaborative to treat severe maternal hypertension.

Additional Information

AttachmentSize
PDF icon P158.pdf359.61 KB
Course summary
Available credit: 
  • 0.50 ACPE Pharmacist
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 CPHQ – Certified Professional Healthcare Quality
  • 0.50 General CE – Attendance
  • 0.50 New Interprofessional Continuing Education (IPCE)
Course opens: 
09/14/2022
Course expires: 
09/21/2023

Faculty

Lisa Landry, BSHS, RRT, NCTTP, CPHQ, Quality and Patient Safety Project Manager, Morristown Medical Center, Morristown, NJ

Laura Geron, DNP, RN, CNL, CPHQ, Quality and Patient Safety Project Manager, Overlook Medical Center, Summit, NJ

Disclosure

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
FDA Off-Label Use
 
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Disclosure Statements
 
Absence of Relevant Financial Relationships
 
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 
 

Credit Types

Interprofessional Continuing Education (IPCE)

This activity was planned by, and for, the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

Nurses (CNE)

Vizient, Inc. designates this enduring material for a maximum of 0.50 ANCC contacts hours.

Pharmacists (CPE)

Vizient, Inc. designates this enduring material for a maximum of 0.50 contact hours for Pharmacists. 

Universal Activity Number: Insert

Physicians (CME)

Vizient, Inc. designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Healthcare Quality Professionals (CPHQ)

This activity is approved by NAHQ® for 0.50 CPHQ CE credits.

Other Healthcare Professionals (General CE Credit)

Vizient, Inc. will award a maximum of 0.50 contact hours to all other healthcare professionals who successfully complete the activity. These individuals will receive a Certificate of Participation indicating the maximum credits available.

Many state licensing boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

 

Available Credit

  • 0.50 ACPE Pharmacist
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 CPHQ – Certified Professional Healthcare Quality
  • 0.50 General CE – Attendance
  • 0.50 New Interprofessional Continuing Education (IPCE)
Please login or register to take this course.

 

Select the Obtain Credit button to access the activity.